Nirmatrelvir, Molnupiravir Use Lowers Risks for Omicron-Infected
MONDAY, Sept. 25, 2023 (HealthDay News) — For patients infected with omicron at high risk for progression to severe disease, treatment with nirmatrelvir or molnupiravir is associated with reductions in mortality and hospitalization, according to a st…
Learn MoreMany Receiving Alpelisib for Metastatic Breast Cancer Have Hyperglycemia
MONDAY, Sept. 25, 2023 (HealthDay News) — For patients with metastatic breast cancer receiving the PI3K inhibitor alpelisib, hyperglycemia often occurs, with a median time to onset of 16 days, according to a study published online Sept. 25 in Cancer….
Learn MoreOzempic: What It Is, Uses, Side Effects & Drug Interactions
Ozempic (semaglutide) is an injectable, prescription-only medication that suppresses appetite and slows down digestion.Here, you will learn more about Ozempic, what it is, what it’s used for, how it works, side effects, drug interactions, foods to avo…
Learn MoreFluticasone Furoate Does Not Cut Time to COVID-19 Symptom Resolution
THURSDAY, Sept. 21, 2023 (HealthDay News) — For outpatients with mild-to-moderate COVID-19, inhaled fluticasone furoate does not shorten time to symptom resolution, according to a study published in the Sept. 21 issue of the New England Journal of Me…
Learn MoreDabrafenib, Trametinib Active in Pediatric Glioma With BRAF V600
THURSDAY, Sept. 21, 2023 (HealthDay News) — Dabrafenib plus trametinib results in significantly more responses and longer progression-free survival than standard chemotherapy for pediatric patients with low-grade glioma with BRAF V600 mutations, acco…
Learn MoreHigher Buprenorphine Dose Increases Likelihood of Staying in Treatment
THURSDAY, Sept. 21, 2023 (HealthDay News) — Patients initiating buprenorphine treatment for opioid use disorder who are prescribed a 24-mg dose are more likely to remain in treatment longer than those prescribed 16 mg, according to a study published …
Learn MoreFDA Wants More Data on First Needle-Free Antidote for Severe Allergic Reactions
WEDNESDAY, Sept. 20, 2023 (HealthDay News) — In a surprising move, the U.S. Food and Drug Administration has opted not to approve a needle-free alternative to the EpiPen for emergency treatment of severe allergic reactions.Approval of the Neffy (epin…
Learn MoreDiabetes Drug Maker Sues Over Compounded Versions of Mounjaro
WEDNESDAY, Sept. 20, 2023 (HealthDay News) — Another diabetes drug maker is taking legal action against businesses in several states, alleging that they are “fraudulently claiming” that their compounded products are the same as its medication.This ti…
Learn MoreProteinuria Higher With Dasatinib Exposure in Chronic Myelogenous Leukemia
WEDNESDAY, Sept. 20, 2023 (HealthDay News) — For patients with chronic myelogenous leukemia (CML) receiving tyrosine-kinase inhibitor therapy, exposure to dasatinib is associated with increased odds of proteinuria, according to a study published onli…
Learn More5-ASA Discontinuation Common Within First Year of Ulcerative Colitis Diagnosis in Youth
WEDNESDAY, Sept. 20, 2023 (HealthDay News) — For adolescents and young adults diagnosed with ulcerative colitis (UC), the rate of discontinuation of 5-aminosalicylic acid (5-ASA) maintenance treatment is high within the first year, according to a stu…
Learn More